Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on November 9, 2026

Nov. 9, 2026

SAB BIO to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 9, 2026

Veru to Present New Results on Effects of Enobosarm on Physical Function in Older Patients Receiving GLP-1 RA from the Phase 2b QUALITY clinical study at ObesityWeek 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200

Indeterminate GlobeNewswire

Nov. 9, 2026

New Data at 2026 American Heart Association Scientific Sessions Highlight Cardiovascular Effects of Sotagliflozin on Thrombus Formation and in Hypertrophic Cardiomyopathy

Indeterminate GlobeNewswire

Nov. 9, 2026

Pliant Therapeutics Announces Presentation of PLN-101095 Preclinical and Clinical Data at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer

Indeterminate GlobeNewswire

Nov. 9, 2026

Celcuity Announces FDA Acceptance of sNDA for REVTORPYK™ (gedatolisib) for HR+/HER2-, PIK3CA Mutant Locally Advanced or Metastatic Breast Cancer

Indeterminate GlobeNewswire

Nov. 9, 2026

Vistagen Provides Regulatory Update Following Productive Type C Meeting with U.S. FDA on Phase 3 Development of Fasedienol for Social Anxiety Disorder

Indeterminate GlobeNewswire

Nov. 9, 2026

Werewolf Therapeutics’ Clinical Data for WTX-124 and WTX-330 Presented at the Society for Immunotherapy of Cancer’s (SITC) 2026 Annual Meeting

Indeterminate GlobeNewswire

Nov. 9, 2026

Santa Ana Bio Presents Preclinical Data on SAB05, a CD40-Targeted Glucocorticoid Antibody-Drug Conjugate, at ACR Convergence 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

NKGen Biotech to Present Long-Term Follow-Up of Troculeucel in Moderate Alzheimer’s Disease at CTAD 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

Tevogen Complements Capital Access with Two-Year Extension to Loan Agreement

Indeterminate GlobeNewswire

Nov. 9, 2026

Evaxion files amendment to registration statement related to 2025 EIB debt settlement agreement

Indeterminate GlobeNewswire

Nov. 9, 2026

Novastra Therapeutics Reports Further Encouraging Clinical Data for Its Novel XIRT™/OAP Cancer Immune Therapy at SITC 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

Amarin Highlights New Data on Lipoprotein(a) and other Apolipoprotein B Containing Lipoproteins at American Heart Association (AHA) Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

Prime Medicine to Present at Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Nov. 9, 2026

Compass Therapeutics Reports 2026 Third Quarter Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 9, 2026

The MUHC Foundation’s second annual Breakthrough Run raises $289,676 to advance research and patient care

Indeterminate GlobeNewswire

Nov. 9, 2026

La deuxième édition de la Course vers la Percée de la Fondation du CUSM recueille 289 676 $ pour faire avancer la recherche et les soins aux patient(e)s

Indeterminate GlobeNewswire

Nov. 9, 2026

The Fur Flies Again: Global Cutest Pets Showdown Returns for Round Two!

Indeterminate GlobeNewswire

Nov. 9, 2026

Humacyte Highlights First-in-Human Coronary Bypass Study at American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire